Ask AI
ProCE Banner Series

Novel Approaches in Relapsed/Refractory Multiple Myeloma: Expert Perspectives on Emerging Data and Ongoing Trials

Join us for this live symposium in conjunction with EHA2026, in which an expert panel will discuss targeting protein degradation pathways for treating patients with relapsed/refractory multiple myeloma.

Please note: You must be registered for the EHA2026 Congress to attend this symposium. You may register at: https://ehaweb.org/connect-network/eha2026-congress/eha2026-registration

  AMA
Who Should Attend

This activity is intended for hematologists, oncologists, and other healthcare professionals who care for patients with multiple myeloma.

All Events

Novel Approaches in Relapsed/Refractory Multiple Myeloma: Expert Perspectives on Emerging Data and Ongoing Trials

Upcoming Events

June

12

2026

7:30 AM - 9:30 AM Central European Time (CET)

In-person

Stockholmsmässan, Massvagen 1, 125 30 Alvsjö, Sweden

8:00 AM - 9:30 AM Central European Time (CET)

Virtual

Topics

Hematologic malignancies, myeloma

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners to optimize the treatment of patients with relapsed/refractory multiple myeloma. 

Target Audience
This activity is intended for hematologists, oncologists, and other healthcare professionals who care for patients with multiple myeloma.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Analyze the impact of binding affinity and potency on the antimyeloma activity of individual novel agents and approaches
  • Evaluate the potential clinical implications of emerging data for novel therapies on treatment of multiple myeloma across the disease continuum
  • Identify patients with multiple myeloma who may be eligible for and likely to benefit from enrollment on clinical trials investigating novel therapies

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

For customer support please click here.

Mailing Address:

 

Decera Clinical
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191